This post is sponsored by International Business Forum.
The healthcare industry has been radically transformed. Consumers continue to take increasing control over their healthcare. This, coupled with the growing aging population, increases the demand for consumer-driven products and services. The advancements of technology have created a growth sector for innovation, investing, alliances and commercialization. Compelling opportunities are motivating corporations, venture capitalists, and consumer product companies to expand, search and support the growing advancements of healthcare technology.
With healthcare technology, social media, and product platforms offering unprecedented ways to engage consumers, the IBF Consumer Health & Wellness Summit on February 9th in Newport Beach, CA, will address how corporations, investors, providers and consumer product companies are capitalizing on this growing market.
Dana Mead, Partner of Kleiner Perkins Caufield & Byers will speak on the panel entitled: “The Future of Personalized Health & Wellness: Best Practices Examined To Provide Growth & Competitive Advantage.”
Richard Migliori, M.D., Executive Vice President, Health Services of UnitedHealth Group will be interviewed by Lisa Suennen, Managing Member of Psilos Group, discussing how payers are adopting and adapting to the consumer health movement.
Jack Young, Senior Investment Manager for Qualcomm Ventures and Ashwin Ram, Research Fellow for PARC, a Xerox Company is sharing perspectives on “The Consumer Health & Wellness Scene: Taking Advantage of Now.”
Herb Schultz, Director of Health & Human Services, Region 9 will give a keynote presentation on the “Government’s Role in Driving Health & Wellness Reform.”
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Brian Witlin, the CEO of ShopWell, and Dennis Boyle, one of the leaders of IDEO’s Health and Wellness practice, will discuss the details of ShopWell’s initiation at IDEO, and its business of enabling customers to shop for healthy food options.
Dirk Lammerts, MD, Managing Director, Digital Health of Burrill & Company to lead a discussion centered on “Consumer Anthropology & Mobile Health: Healthcare Technology To Support Consumer Behavior.”
Attendance by AcuFocus, Apax Partners, MDVIP, Navigenics, Procter & Gamble, Physic Ventures, Keas, RedBrick Health, SeeChange Health, Chrysalis Ventures, Sherbrooke Capital, University of Minnesota, Versant Ventures — just to name a few.
To learn more about this program, please visit IBF’s Consumer Health & Wellness Innovation Summit website.
If you want to register, feel free to contact Cathy Fenn of IBF at [email protected] and mention the code of CHMED for the discounted fee of $795.00.
